505(b)(2) Patent Certifications Attach To Reference Drug, Not Drug Substance

A 505(b)(2) NDA sponsor need only certify to patents for the reference listed drug product, not all patents associated with a drug substance, FDA said in rejecting an Abbott citizen petition regarding fenofibrate Nov. 30